Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05422625 · ClinicalTrials.gov registry record · NA
PTNS for Female Patients Suffering From Multiple Sclerosis
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05422625 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 2 participants.
The verdict
NCT05422625, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a pilot, single blind, randomized, sham-controlled trial to assess the benefit of Percutaneous Tibial Nerve Stimulation (PTNS) in treating bladder overactivity (OAB) symptoms in multiple sclerosis (MS) patients. The data generated by this study would provide support for a future multi-institutional, randomized prospective trial.
Interventions
- DEVICE PTNS Treatment
- DEVICE Sham PTNS Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-01-09 |
| Est. Completion | 2023-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05422625
The ClinicalTrials.gov registry entry for NCT05422625 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PTNS Treatment is the first listed.
NCT05422625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05422625 about?
NCT05422625 is a clinical study titled "PTNS for Female Patients Suffering From Multiple Sclerosis". This is a pilot, single blind, randomized, sham-controlled trial to assess the benefit of Percutaneous Tibial Nerve Stimulation (PTNS) in treating bladder overactivity (OAB) symptoms in multiple sclerosis (MS) patients. The data generated by this study would provide support for a future multi-instit...
What is the current status of trial NCT05422625?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-01-09. Estimated completion is 2023-08-03.
What interventions are being tested in trial NCT05422625?
The interventions under investigation include: PTNS Treatment (DEVICE), Sham PTNS Treatment (DEVICE).
Who is sponsoring clinical trial NCT05422625?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.